Table 4. Outcomes of ranking from all RCTs.

	Proteinuria reduction	BP reduction	eGFR reduction
Placebo	10(16%)	7 (14%)	2(24%)
candesartan	13(14%)	/	/
candesartan+trandolapril	/	1 (37%)	/
enalapril	9(12%)	3 (20%)	7(86%)
fosinopril	14 (16%)	/	5(22%)
lisinopril	2(12%)	/	6(48%)
lisinopril+losartan	/	/	/
losartan	5(14%)	6(22%)	4(32%)
losartan+ enalapril	/	2(32%)	/
olmesartan	2(12%)	5(13%)	/
olmesartan + temocapril	1(22%)	/	/
temocapril	3(15%)	8(17%)	2 (24%)
temocapril+losartan	/	3 (14%)	1(35%)
trandolapril	/	11(51%)	/

Notes.

For Proteinuria reduction, rank 1 is best, rank N is worst.

For eGFR reduction, rank N is best, rank 1 is worst.

For BP reduction, rank N is best, rank 1 is worst.

Values are ranking number (probability).